Carvacrol Improves Vascular Function in Hypertensive Animals by Modulating Endothelial Progenitor Cells

Area of Science:

• Cardiovascular Research
• Pharmacology
• Cell Biology

Background:

• Carvacrol, a phenolic monoterpene, exhibits antioxidant and antihypertensive properties.
• Limited evidence exists on carvacrol's role in vascular regeneration.
• Endothelial progenitor cells (EPCs) are crucial for repairing damaged blood vessels.

Purpose of the Study:

• To investigate carvacrol's effect on endothelial repair mediated by EPCs in spontaneously hypertensive rats (SHR).
• To assess carvacrol's impact on EPC function and vascular health in a hypertensive model.

Main Methods:

• SHR and Wistar Kyoto (WKY) rats were treated with carvacrol, vehicle, or resveratrol for four weeks.
• Systolic blood pressure (SBP) was monitored weekly.
• EPCs were isolated, quantified, and their functionality assessed (CFU, eNOS, ROS, senescence).
• Vascular tissues (superior mesenteric artery) were analyzed for ROS, CD34, and CD31 expression.

Main Results:

• Carvacrol treatment improved EPC migration, colony-forming unit (CFU) formation, and eNOS expression/activity.
• Carvacrol reduced intracellular reactive oxygen species (ROS) and senescence in EPCs.
• Vascular ROS levels decreased, while CD31 and CD34 expression increased following carvacrol treatment.

Conclusions:

• Carvacrol significantly enhances EPC functionality, contributing to improved endothelial repair.
• Carvacrol demonstrates potential in mitigating endothelial dysfunction and promoting vascular health in hypertension.
• These findings suggest carvacrol as a promising therapeutic agent for vascular regeneration.